Health
An existing drug may function as targeted therapy for ALL in children – News-Medical.Net
A new study from Linköping University has shown that the tumour-inhibiting gene TET2 is silenced in a large fraction of cases…
A new study from Linköping University has shown that the tumor-inhibiting gene TET2 is silenced in a large fraction of cases of acute lymphoblastic leukemia (ALL) in children. The scientists show that the gene can be reactivated by treatment with an existing…
Continue Reading
-
Noosa News21 hours agoDid you lose your ring?
-
Business24 hours agoWill GQG Partners shares rise from here? Macquarie reveals its forecast post-results
-
Noosa News20 hours agoThe only person detained at Brisbane’s Palestine rally
-
General21 hours agoHousing bubble warning as deposit scheme fast-tracked